[1] Bull L N, van Eijk M J, Pawlikowska L, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis[J]. Nat Genet,1998,18(3):219-224.
[2] 李晓鹤,饶慧瑛.遗传代谢相关肝内胆汁淤积症的诊治进展[J].医学综述,2019,25(15):2955-2960.
[3] Summerskill W H, Walshe J M. Benign recurrent intrahepatic ‘obstructive’ jaundice[J]. Lancet,1959,2(7105):686-690.
[4] 钟嫦,周晓东.IgG4相关性硬化性胆管炎诊疗进展[J].中国实用内科杂志,2019,39(3):297-301.
[5] 尤红,段维佳,李淑香,等.原发性胆汁性胆管炎的诊断和治疗指南(2021)[J].临床肝胆病杂志,2022,38(1):35-41.
[6] Luketic V A,Shiffman M L.Benign recurrent intrahepatic cholestasis[J]. Clin Liver Dis,2004,8(1):133-149,vii.
[7] 陈成伟,成军,窦晓光,等.胆汁淤积性肝病诊断和治疗共识(2015)[J].临床肝胆病杂志,2015,31(12):1989-1999.
[8] 任艳,孔明,刘晖,等.五例良性复发性肝内胆汁淤积患者临床特点分析[J].北京医学,2020,42(6):485-488.
[9] 吴秀丽.良性复发性肝内胆汁淤积症1型1例[J].肝脏, 2018,23(5):462-463.Med,2016,39:27522.
[10] 赵俊波,袁林,周颖蕾,等.ATP8B1基因突变致良性复发性肝内胆汁淤积症1例报道并临床及分子病理特点分析[J].胃肠病学和肝病学杂志,2020,29(12):1437-1440.
[11] 谢丛,张航,孟毓珊,等.良性复发性肝内胆汁淤积1例[J].临床消化病杂志,2023,35(4):325-327.
[12] 徐铭益,陆伦根.良性复发性肝内胆汁淤积诊治进展[J].中国医学前沿杂志(电子版),2015,7(4):5-9.
[13] 沈镇扬,陆伦根.考来烯胺预防难治性良性复发性肝内胆汁淤积1型胆汁淤积发作[J].肝脏,2021,26(10):1077-1079.
[14] Schoeneich K, Frimmel S, Koball S. Successful treatment of a patient with benign recurrent intrahepatic cholestasis type 1 with albumin dialysis[J]. Artif Organs,2020,44:341-342.
[15] Oldakowska-Jedynak U, Jankowska I, Hartleb M, et al. Treatment of pruritus with prometheus dialysis and absorption system in a patient with benign recurrent intrahepatic cholestasis[J]. Hepatol Res,2014,44:304-308.
[16] Yakar T, Demir M, Gokturk H S, et al. Nasobiliary drainage for benign recurrent intrahepatic cholestasis in patients refractory to standard therapy[J]. Clin Invest Med,2016,39:27522.
[17] 邢文山.良性复发性肝内胆汁淤积的中西医结合治疗[J].中国民间疗法,2015,23(6):74-75.
[18] Halawi A, Ibrahim N, Bitar R. Triggers of benign recurrent intrahepatic cholestasis and its pathophysiology: a review of literature[J]. Acta Gastroenterol Belg,2021,84(3):477-486.
[19] 汪芾,汪皓琪,周怡,等.3例良性复发性肝内胆汁淤积症患者临床特点分析[J].实用肝脏病杂志,2023,26(1):47-50. |
